Page last updated: 2024-08-16

salmeterol xinafoate and Body Weight

salmeterol xinafoate has been researched along with Body Weight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moore, NG; Pegg, GG; Sillence, MN1
Argilés, JM; Carbó, N; González, O; Llovera, M; López-Soriano, FJ; López-Soriano, J; Tarragó, T1

Other Studies

2 other study(ies) available for salmeterol xinafoate and Body Weight

ArticleYear
Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration.
    The American journal of physiology, 1994, Volume: 267, Issue:3 Pt 1

    Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Animals; Appetite; Body Weight; Clenbuterol; Cyclic AMP; Dose-Response Relationship, Drug; Female; Heart; Infusion Pumps; Injections, Intraperitoneal; Muscles; Organ Size; Rats; Rats, Wistar; Salmeterol Xinafoate

1994
Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth.
    Cancer letters, 1997, May-01, Volume: 115, Issue:1

    Topics: Adipose Tissue; Adrenergic beta-Agonists; Albuterol; Animals; Body Weight; Cachexia; Clenbuterol; Eating; Liver Neoplasms, Experimental; Male; Muscle Proteins; Muscular Atrophy; Rats; Rats, Wistar; Salmeterol Xinafoate

1997